← Leaderboards
Julia H. Arnsten
Montefiore Medical Center (Bronx, Ny)
$18,953,214
Attributed
$29,858,803
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,858,803 · 9
By mechanism
RM1$13,727,424 · 1
R01$11,366,643 · 4
R25$4,049,137 · 2
P20$522,470 · 1
P30$193,129 · 1
Top collaborators
- Monica G Rivera-Mindt6 shared
- Vilma Gabbay5 shared
- Joanna L. Starrels5 shared
- Yuhua Bao1 shared
Most similar at Montefiore Medical Center (Bronx, Ny)
Same institution · by research overlap
- Kathryn M Anastos$101,132,545
- Jonathan Shuter$10,395,290
- Pinka Chatterji$799,208
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsEpidemiologyInnovationTrainingHiv InfectionsResearch PersonnelResourcesMentorsDrug UserDrug AddictionMethadoneResearch Project GrantsDiagnosisInstitutionPhysiciansFundingRecording Of Previous EventsProgramsDesignCaringBuprenorphineCommunitiesClinical ResearchDrug Abuse
Grant awards (43)
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$2,465,699
RM1 · FY2025 · DA
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$1,328,798
RM1 · FY2025 · DA
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$2,371,942
RM1 · FY2024 · DA
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$2,428,171
RM1 · FY2023 · DA
Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$5,132,814
RM1 · FY2021 · DA
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$733,464
R01 · FY2021 · DA · contact PI
Patient and Population Health Outcomes Research SWG$40,677
P30 · FY2021 · AI · contact PI
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?$751,280
R01 · FY2020 · DA · contact PI
Patient and Population Health Outcomes Research SWG$40,060
P30 · FY2020 · AI · contact PI
Patient and Population Health Outcomes Research SWG$38,867
P30 · FY2019 · AI · contact PI
Patient and Population Health Outcomes Research SWG$14,579
P30 · FY2018 · AI · contact PI
Patient and Population Health Outcomes Research SWG$6,946
P30 · FY2018 · AI · contact PI
Patient and Population Health Outcomes Research SWG$52,000
P30 · FY2017 · AI · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$614,813
R01 · FY2016 · DA · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$520,108
R01 · FY2015 · DA · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$109,119
R01 · FY2015 · DA · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$675,282
R01 · FY2014 · DA · contact PI
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program$235,949
R25 · FY2014 · DA · contact PI
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program$117,975
R25 · FY2014 · DA · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$658,835
R01 · FY2013 · DA · contact PI
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program$344,842
R25 · FY2013 · DA · contact PI
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug Users$708,322
R01 · FY2012 · DA · contact PI
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program$367,343
R25 · FY2012 · DA · contact PI
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) Program$375,598
R25 · FY2011 · DA · contact PI
Neurocognitive Effects of Buprenorphine Among HIV+ Opioid Users$165,637
P20 · FY2011 · DA · contact PI
Clinical Addiction Research and Education Program$322,728
R25 · FY2010 · DA · contact PI
Neurocognitive Effects of Buprenorphine Among HIV+ Opioid Users$171,279
P20 · FY2010 · DA · contact PI
Clinical Addiction Research and Education Program$325,987
R25 · FY2009 · DA · contact PI
Neurocognitive Effects of Buprenorphine Among HIV+ Opioid Users$185,554
P20 · FY2009 · DA · contact PI
Clinical Addiction Research and Education Program$325,987
R25 · FY2008 · DA · contact PI
Efficacy and cost of HAART DOT in methadone clinics$584,081
R01 · FY2007 · DA · contact PI
Clinical Addiction Research and Education Program$332,640
R25 · FY2007 · DA · contact PI
Efficacy and cost of HAART DOT in methadone clinics$1,070,849
R01 · FY2006 · DA · contact PI
Efficacy and cost of HAART DOT in methadone clinics$1,067,167
R01 · FY2005 · DA
CLINICAL ADDICTION RESEARCH AND EDUCATION (CARE) PROGRAM$337,133
R25 · FY2005 · DA
Efficacy and cost of HAART DOT in methadone clinics$1,038,565
R01 · FY2004 · DA
CLINICAL ADDICTION RESEARCH AND EDUCATION (CARE) PROGRAM$328,120
R25 · FY2004 · DA
Efficacy and cost of HAART DOT in methadone clinics$1,017,554
R01 · FY2003 · DA
CLINICAL ADDICTION RESEARCH AND EDUCATION (CARE) PROGRAM$319,366
R25 · FY2003 · DA
CLINICAL ADDICTION RESEARCH AND EDUCATION (CARE) PROGRAM$315,469
R25 · FY2002 · DA
HIV THERAPY ADHERENCE AND VIRAL RESISTANCE IN DRUG USERS$202,085
R01 · FY2002 · DA
HIV THERAPY ADHERENCE AND VIRAL RESISTANCE IN DRUG USERS$768,624
R01 · FY2001 · DA
HIV THERAPY ADHERENCE AND VIRAL RESISTANCE IN DRUG USERS$846,495
R01 · FY2000 · DA